SG Americas Securities’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-5,993
| Closed | -$212K | – | 3399 |
|
|
2026
Q1 | $212K | Sell |
5,993
-6,883
| -53% | -$280K | ﹤0.01% | 2606 |
|
|
2025
Q4 | $523K | Sell |
12,876
-51,018
| -80% | -$2.22M | ﹤0.01% | 2463 |
|
|
2025
Q3 | $3M | Buy |
63,894
+61,860
| +3,041% | +$3.21M | 0.01% | 734 |
|
|
2025
Q2 | $106K | Sell |
2,034
-2,298
| -53% | -$126K | ﹤0.01% | 2614 |
|
|
2025
Q1 | $262K | Buy |
+4,332
| New | +$279K | ﹤0.01% | 2326 |
|
|
2024
Q4 | – | Sell |
-10,924
| Closed | -$786K | – | 3205 |
|
|
2024
Q3 | $786K | Buy |
10,924
+5,903
| +118% | +$417K | ﹤0.01% | 1282 |
|
|
2024
Q2 | $348K | Buy |
5,021
+2,601
| +107% | +$190K | ﹤0.01% | 1885 |
|
|
2024
Q1 | $194K | Sell |
2,420
-622
| -20% | -$55.4K | ﹤0.01% | 1995 |
|
|
2023
Q4 | $333K | Sell |
3,042
-20,630
| -87% | -$2.13M | ﹤0.01% | 1744 |
|
|
2023
Q3 | $2.39M | Buy |
+23,672
| New | +$2.72M | 0.03% | 623 |
|
|
2023
Q2 | – | Sell |
-10,298
| Closed | -$1.07M | – | 2431 |
|
|
2023
Q1 | $1.07M | Buy |
10,298
+1,154
| +13% | +$112K | 0.01% | 1096 |
|
|
2022
Q4 | $811K | Sell |
9,144
-3,980
| -30% | -$330K | 0.01% | 1112 |
|
|
2022
Q3 | $1.05M | Buy |
13,124
+1,362
| +12% | +$128K | 0.01% | 981 |
|
|
2022
Q2 | $1.13M | Buy |
11,762
+9,034
| +331% | +$1.08M | 0.01% | 1202 |
|
|
2022
Q1 | $405K | Buy |
+2,728
| New | +$381K | ﹤0.01% | 2015 |
|
|
2021
Q4 | – | Sell |
-19,445
| Closed | -$2.54M | – | 3436 |
|
|
2021
Q3 | $2.54M | Sell |
19,445
-7,332
| -27% | -$959K | 0.01% | 1057 |
|
|
2021
Q2 | $3.68M | Buy |
26,777
+24,851
| +1,290% | +$3.4M | 0.02% | 757 |
|
|
2021
Q1 | $252K | Buy |
+1,926
| New | +$232K | ﹤0.01% | 2514 |
|
|
2020
Q3 | – | Sell |
-3,770
| Closed | -$271K | – | 2818 |
|
|
2020
Q2 | $271K | Sell |
3,770
-73,857
| -95% | -$5.14M | ﹤0.01% | 2590 |
|
|
2020
Q1 | $4.45M | Buy |
77,627
+60,521
| +354% | +$5.58M | 0.04% | 423 |
|
|
2019
Q4 | $1.91M | Buy |
17,106
+4,511
| +36% | +$481K | 0.02% | 847 |
|
|
2019
Q3 | $1.21M | Sell |
12,595
-4,935
| -28% | -$463K | 0.01% | 1280 |
|
|
2019
Q2 | $1.5M | Buy |
17,530
+16,235
| +1,254% | +$1.33M | 0.01% | 1189 |
|
|
2019
Q1 | $108K | Sell |
1,295
-10,862
| -89% | -$789K | ﹤0.01% | 3016 |
|
|
2018
Q4 | $780K | Buy |
12,157
+4,490
| +59% | +$307K | 0.01% | 1535 |
|
|
2018
Q3 | $607K | Sell |
7,667
-868
| -10% | -$67.1K | ﹤0.01% | 2015 |
|
|
2018
Q2 | $625K | Buy |
8,535
+4,980
| +140% | +$339K | 0.01% | 1832 |
|
|
2018
Q1 | $225K | Sell |
3,555
-3,542
| -50% | -$211K | ﹤0.01% | 2354 |
|
|
2017
Q4 | $362K | Sell |
7,097
-1,919
| -21% | -$99.9K | ﹤0.01% | 2051 |
|
|
2017
Q3 | $473K | Buy |
9,016
+6,839
| +314% | +$343K | ﹤0.01% | 1891 |
|
|
2017
Q2 | $111K | Buy |
+2,177
| New | +$108K | ﹤0.01% | 2842 |
|
|
2016
Q4 | – | Sell |
-4,318
| Closed | -$173K | – | 3155 |
|
|
2016
Q3 | $173K | Buy |
+4,318
| New | +$183K | ﹤0.01% | 2615 |
|
|
2016
Q2 | – | Sell |
-2,816
| Closed | -$118K | – | 2656 |
|
|
2016
Q1 | $118K | Buy |
+2,816
| New | +$111K | ﹤0.01% | 2528 |
|
|
2015
Q4 | – | Sell |
-2,644
| Closed | -$126K | – | 2731 |
|
|
2015
Q3 | $126K | Buy |
2,644
+172
| +7% | +$9.44K | ﹤0.01% | 1726 |
|
|
2015
Q2 | $144K | Buy |
+2,472
| New | +$133K | ﹤0.01% | 2153 |
|
|
2015
Q1 | – | Sell |
-5,912
| Closed | -$266K | – | 2595 |
|
|
2014
Q4 | $266K | Buy |
+5,912
| New | +$248K | ﹤0.01% | 2170 |
|
|
2013
Q4 | – | Sell |
-4,578
| Closed | -$156K | – | 2699 |
|
|
2013
Q3 | $156K | Buy |
+4,578
| New | +$149K | ﹤0.01% | 2359 |
|
Other funds holding CNMD
ICM
SG Americas Securities's CNMD Position: Q2 2026 in Review
SG Americas Securities sold out of CONMED (CNMD) in Q2 2026, closing a stake of 5,993 shares — an estimated $212K sold.
SG Americas Securities first reported a position in CNMD in Q3 2013 and held it in 37 quarters. The position peaked at $4.45M in Q1 2020. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- SG Americas Securities reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
- SG Americas Securities sold 5,993 CONMED shares in Q2 2026, an estimated $212K.
- SG Americas Securities first reported a position in CONMED in Q3 2013 and held it in 37 quarters.
- SG Americas Securities's CONMED position peaked at $4.45M in Q1 2020.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.